LIVER INTERNATIONAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2016-08-02 ifmorethanten

一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表::
请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？

刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？

359 0

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2016-06-13 刘昱含

请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表::
研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！

HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！

401 0

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2015-09-14 133.5.64.89

审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09

413 0

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2015-08-22 HANHAN2010

审稿速度:2.0 | 投稿命中率:50.0
经验分享：一个半月审稿，小修后一周接收（2015.8）
偏重临床，审稿仔细认真，很受用！

336 0

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2015-02-03 sumer

审稿速度:1.0 | 投稿命中率:25.0
经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。

398 0

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2014-03-06 匿名用户

审稿速度:2.0 | 投稿命中率:50.0
经验分享：初次投稿到 major revision 1个半月
修回到 minor revision 1个月
再次修回到 accept 10天

分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。
急用，希望快点online.

466 0

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2013-06-19 匿名用户

awaiting ED decision 要多久？

589 0

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2013-05-16 匿名用户

质量越来越好，要求越来越高！

529 0

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2013-03-18 匿名用户

投稿两月后，大修。
修回1个半月后，小修。
再次修回，现在underreview中

531 0

[GetPortalCommentsPageByObjectIdResponse(id=525441, encodeId=eb3c52544137, content=一般很少有杂质会让你提供这些的。你需要提供的一般是你们单位伦理审批的编号以及说上一句话：“所有病人都已经知情并同意使用样本”。但是按理来说你确实是应该有知情同意书，并让患者签字的。刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, beContent=刘昱含 2016-06-13 发表:: 请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Aug 02 21:25:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523449, encodeId=178d523449aa, content=请问需要患者知情同意书吗？患者签字的扫描件害怕，就知情同意书的表格就行？HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, beContent=HANHAN2010 2015-08-22 发表:: 研究方向：临床;基础; 接收率：约50% 审稿时间：约2个月一个半月审稿，小修后一周接收（2015.8）偏重临床，审稿仔细认真，很受用！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOSxCzFLnCWCGKiayZm6CofoxDB4ZKVvtJ0We3UjspTxibrRvVatTaDJBjWibmafDsiayUXpxVAvH14Q/132, createdBy=f2e21681525, createdName=刘昱含, createdTime=Mon Jun 13 23:06:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515313, encodeId=8bd2515313ec, content=审稿一个半月，小修后8天接收，接收18天后online.神速！ 2015.09, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=133.5.64.89, createdTime=Mon Sep 14 08:10:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514727, encodeId=c291514e27b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一个半月审稿，小修后一周接收（2015.8） 偏重临床，审稿仔细认真，很受用！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07501630443, createdName=HANHAN2010, createdTime=Sat Aug 22 11:54:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509541, encodeId=873b509541c3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我们科投了几篇临床文章，都很快在编辑手上拒了。对这杂志不是特别有好感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Tue Feb 03 16:53:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501604, encodeId=9c76501604bd, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：初次投稿到 major revision 1个半月 修回到 minor revision 1个月 再次修回到 accept 10天 分析了已发表的全文，接收后1个月内先online，然后就等待正式出版。 急用，希望快点online., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Mar 06 20:03:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496392, encodeId=c178496392ec, content=awaiting ED decision 要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 19 13:36:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495785, encodeId=b9af495e8516, content=质量越来越好，要求越来越高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=529, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 16 10:55:00 CST 2013, time=2013-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494415, encodeId=82134944150a, content=投稿两月后，大修。 修回1个半月后，小修。 再次修回，现在underreview中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 18 15:45:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492817, encodeId=e12a49281ea4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间为2-3个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=558, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ea533159, createdName=spaceboy59, createdTime=Sun Dec 09 23:09:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

2012-12-09 spaceboy59

审稿速度:3.0 | 投稿命中率:25.0
经验分享：审稿时间为2-3个月。

558 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务